logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Factors associated with the use of various medications amongst patients with severe coronary artery disease.

    Article - En anglais

    Aim

    To describe variations by age, sex, symptom severity and hospital region in the use of various medications amongst patients with stable angina pectoris who are candidates for coronary revascularization.

    Patients

    Patients (n=2030) with chronic stable angina pectoris participating in a national survey evaluating the appropriateness of the use of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG).

    Methods

    As part of a national study of the appropriateness of coronary revascularization, data were prospectively collected on patients referred for consideration of coronary revascularization to seven of the eight public Swedish heart centres that performed approximately 92% of all bypass operations in Sweden in 1994.

    Results

    Amongst all patients 76% were treated with beta blockers. 41% with calcium antagonists and 71% with long-acting nitrates and 70% were treated with at least two of these three drugs.

    Eighty-two per cent of the patients used aspirin and 14% lipid-lowering drugs.

    According to logistic regression analysis, with medication as the dependent variable and independent variables of age, sex, angina functional class, findings at exercise test, history of various diseases and region in Sweden where the investigation took place, the most consistent factor explaining the use of various medications was found to be geographical region. (...)

    Mots-clés Pascal : Cardiopathie coronaire, Homme, Antiangoreux, Traitement, Chimiothérapie, Epidémiologie, Suède, Europe, Pratique professionnelle, Critère décision, Appareil circulatoire pathologie

    Mots-clés Pascal anglais : Coronary heart disease, Human, Antianginal agent, Treatment, Chemotherapy, Epidemiology, Sweden, Europe, Professional practice, Decision criterion, Cardiovascular disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0130976

    Code Inist : 002B12A03. Création : 16/11/1999.